These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10461880)

  • 1. Extensive alternative splicing in the 5'-untranslated region of the rat and human neuropeptide Y Y5 receptor genes regulates receptor expression.
    Parker EM; Xia L
    J Neurochem; 1999 Sep; 73(3):913-20. PubMed ID: 10461880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.
    Rodriguez M; Audinot V; Dromaint S; Macia C; Lamamy V; Beauverger P; Rique H; Imbert J; Nicolas JP; Boutin JA; Galizzi JP
    Biochem J; 2003 Feb; 369(Pt 3):667-73. PubMed ID: 12398768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation.
    Herzog H; Darby K; Ball H; Hort Y; Beck-Sickinger A; Shine J
    Genomics; 1997 May; 41(3):315-9. PubMed ID: 9169127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.
    Schaffhauser AO; Stricker-Krongrad A; Brunner L; Cumin F; Gerald C; Whitebread S; Criscione L; Hofbauer KG
    Diabetes; 1997 Nov; 46(11):1792-8. PubMed ID: 9356028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning, organization and localization of the gene for the mouse neuropeptide Y-Y5 receptor.
    Nakamura M; Yokoyama M; Watanabe H; Matsumoto T
    Biochim Biophys Acta; 1997 Sep; 1328(2):83-9. PubMed ID: 9315606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of the guinea pig neuropeptide Y receptor Y5.
    Lundell I; Eriksson H; Marklund U; Larhammar D
    Peptides; 2001 Mar; 22(3):357-63. PubMed ID: 11287090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y Y5 receptor expression.
    Parker EM
    Methods Mol Biol; 2000; 153():53-60. PubMed ID: 10957984
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic studies of neuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity.
    Roche C; Boutin P; Dina C; Gyapay G; Basdevant A; Hager J; Guy-Grand B; Clément K; Froguel P
    Diabetologia; 1997 Jun; 40(6):671-5. PubMed ID: 9222646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
    Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
    Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites.
    Statnick MA; Schober DA; Gackenheimer S; Johnson D; Beavers L; Mayne NG; Burnett JP; Gadski R; Gehlert DR
    Brain Res; 1998 Nov; 810(1-2):16-26. PubMed ID: 9813224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple promoters regulate tissue-specific expression of the human NPY-Y1 receptor gene.
    Ball HJ; Shine J; Herzog H
    J Biol Chem; 1995 Nov; 270(45):27272-6. PubMed ID: 7592987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
    Kanatani A; Ishihara A; Iwaasa H; Nakamura K; Okamoto O; Hidaka M; Ito J; Fukuroda T; MacNeil DJ; Van der Ploeg LH; Ishii Y; Okabe T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 2000 May; 272(1):169-73. PubMed ID: 10872822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for mutations in the neuropeptide Y Y5 receptor gene in cohorts belonging to different weight extremes.
    Rosenkranz K; Hinney A; Ziegler A; von Prittwitz S; Barth N; Roth H; Mayer H; Siegfried W; Lehmkuhl G; Poustka F; Schmidt M; Schäfer H; Remschmidt H; Hebebrand J
    Int J Obes Relat Metab Disord; 1998 Feb; 22(2):157-63. PubMed ID: 9504324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells.
    Moser C; Bernhardt G; Michel J; Schwarz H; Buschauer A
    Can J Physiol Pharmacol; 2000 Feb; 78(2):134-42. PubMed ID: 10737676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a novel neuropeptide Y receptor subtype involved in food intake: an in situ hybridization study of Y5 mRNA distribution in rat brain.
    Durkin MM; Walker MW; Smith KE; Gustafson EL; Gerald C; Branchek TA
    Exp Neurol; 2000 Sep; 165(1):90-100. PubMed ID: 10964488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
    Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
    Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
    Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.